Skip to main content
. 2021 Sep 15;11(9):4485–4499.

Table 2.

Characteristics of liver transplant recipients with HCC from a validation cohort

Parameters With recurrence (n=49) Without recurrence (106) P
Age 53.02±8.05 54.42±8.24 0.322
Sex (male) 45 99 0.988
Maintenance 0.355
    Tacrolimus 38 89
    Cyclosporin A 11 17
Tumor-free survival (months) 16.69±9.47 28.32±14.58 0.000
Status (alive) 18 102 0.000
Cum survival (months) 26.33±13.20 28.32±14.58 0.416